Bottom line
What is RXL's expense ratio?
RXL's expense ratio is 0.95%, or about $95 a year on every $10,000 invested. That is cheaper than 50% of health care sector funds we track (median 0.96%).
Updated Sep 25, 2026
RXL fee table
| Net expense ratio | 0.95% |
|---|---|
| Gross expense ratio | 1.08% |
| Management fee | 0.75% |
| Other expenses | 0.33% |
| Fee waiver / reimbursement | -0.13% |
| Max front-end sales load | None (ETF) |
Source: Fund prospectus fee table, filed Sep 25, 2026
What RXL costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| RXL | $97 | $331 | $583 | $1,305 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.95% expense ratio costs roughly $52,800 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheaper alternatives to RXL
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.